Mark Nelson

Stocks To Watch: Callon Petroleum Company (CPE), Amyris, Inc. (AMRS), Sino-Global Shipping America, Ltd. (SINO)

Callon Petroleum Company (CPE) traded within a range of $14.68 to $15.02 after opening the day at $14.73. The company has seen its stock decrease in value by -2.93% so far this year. The stock was up close to 0.47% on light volume in last trading session and closed at $14.92 per share. After the recent gain, the stock is currently holding -19.48% below its 52 week high of $18.53 and 161.75% above its 12-month low of $5.7. The shares are up by over 6.5% in the last three months, and the RSI indicator value of 49.33 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Callon Petroleum Company, an independent oil and natural gas company, acquires, explores for, develops, and produces oil and natural gas properties in the Permian Basin in West Texas. As of December 31, 2015, the company estimated net proved reserves totaled 54.3 million barrel of oil equivalent. Callon Petroleum Company was founded in 1950 and is headquartered in Natchez, Mississippi.

Amyris, Inc. (AMRS) continued its downward trend with the stock declining -6.79% or $-0.04 to close the day at $0.52 on active trading volume of 4.46M shares, compared to its three month average trading volume of 2.18M. The Emeryville California 94608 based company has been underperforming the specialty chemicals group over the past 52 weeks, with the stock losing -64.97%, compared to the industry which has advanced 33.12% over the same period. With RSI of 39.38, the stock should still continue to rise and get closer to its one year target estimate of $2.77, making it a hold for now.

Amyris, Inc. provides various alternatives to a range of petroleum-sourced products worldwide. The company uses its industrial bioscience technology to design microbes primarily yeast, as well as to convert plant-sourced sugars into renewable hydrocarbons. It produces and sells Biofene that converts to squalane, which is used as an emollient in cosmetics and other personal care products; and natural oils and aroma chemicals for the flavors and fragrances market. The company also provides renewable solvents, polymers, and renewable lubricants for industrial applications; and renewable fuels for transportation fuels market. It has a collaboration partnership with Total S.A. to produce and commercialize Biofene-based diesel and jet fuels. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was founded in 2003 and is headquartered in Emeryville, California.

Sino-Global Shipping America, Ltd. (SINO) dropped $-1.08 to close the day at a new closing price of $3.33, a -24.49% decrease in value from its previous closing price that moved the stock 732.5% above its 52 week low of $0.4. A total of 4.46M shares exchanged hands during the day compared with its three month average trading volume of 2.52M. The stock, which fluctuated between $3.21 and $3.75 during the day, currently situated -76.55% below its 52 week high. The stock is up by 7.77% in the past one month and up by 86.03% over the past three months. With a one year target estimate of $0 and RSI of 51.25, the stock still has upside potential, making it a hold for now.

Sino-Global Shipping America, Ltd. provides shipping agency and inland transportation management services in the United States, the People’s Republic of China, Australia, and Canada. Its shipping agency services include loading/discharging and protective services. The company was founded in 2001 and is headquartered in Roslyn, New York.

 

Stocks in Review: Synergy Pharmaceuticals Inc. (SGYP), Sunstone Hotel Investors, Inc. (SHO), Boyd Gaming Corporation (BYD)

Synergy Pharmaceuticals Inc. (SGYP) traded within a range of $6.24 to $6.43 after opening the day at $6.27. The company has seen its stock increase in value by 3.94% so far this year. The stock was up close to 0.48% on light volume in last trading session and closed at $6.33 per share. After the recent gain, the stock is currently holding -11.47% below its 52 week high of $7.15 and 153.2% above its 12-month low of $2.5. The shares are up by over 11.25% in the last three months, and the RSI indicator value of 54.66 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Synergy Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases. Its lead product candidate is plecanatide, a guanylyl cyclase C receptor agonist that is in Phase III clinical trials to treat chronic idiopathic constipation GI disorders; and for the treatment of constipation-predominant irritable bowel syndrome GI disorders. The company is also developing SP-333, which is in Phase II clinical trials to treat opioid induced constipation, as well as in Phase Ib clinical trials to treat ulcerative colitis. The company has a research collaboration with BIND Therapeutics, Inc. to develop ACCURINS for treatment of a range of cells with novel therapeutic payloads. Synergy Pharmaceuticals Inc. is headquartered in New York, New York.

Sunstone Hotel Investors, Inc. (SHO) continued its upward trend with the stock climbing 0.84% or $0.13 to close the day at $15.56 on active trading volume of 3.21M shares, compared to its three month average trading volume of 2.56M. The Aliso Viejo California 92656 based company has been outperforming the reit – hotel/motel group over the past 52 weeks, with the stock gaining 32.33%, compared to the industry which has advanced 28.42% over the same period. With RSI of 63.89, the stock should still continue to rise and get closer to its one year target estimate of $14.85, making it a hold for now.

Sunstone Hotel Investors, Inc. operates as a real estate investment trust. The firm engages in the acquisition, ownership, asset management, renovation, and sale of luxury, upper upscale, and upscale full-service hotels in the United States. Its portfolio also includes mid-scale hotels. Sunstone Hotel Investors was founded in 1995 and is based in Aliso Viejo, California.

Boyd Gaming Corporation (BYD) gained $0.67 to close the day at a new closing price of $21.33, a 3.24% increase in value from its previous closing price that moved the stock 37.26% above its 52 week low of $15.28. A total of 3.2M shares exchanged hands during the day compared with its three month average trading volume of 1.24M. The stock, which fluctuated between $20.85 and $21.5 during the day, currently situated -1.16% below its 52 week high. The stock is up by 8.88% in the past one month and up by 13.58% over the past three months. With a one year target estimate of $22.77 and RSI of 63.99, the stock still has upside potential, making it a hold for now.

Boyd Gaming Corporation, together with its subsidiaries, operates as a multi-jurisdictional gaming company. It operates in five segments: Las Vegas Locals, Downtown Las Vegas, Midwest and South, Peninsula, and Borgata. The company owns and operates 21 gaming entertainment properties located in Nevada, Illinois, Indiana, Iowa, Kansas, Louisiana, Mississippi, and New Jersey. It also owns and operates a travel agency and a captive insurance company that underwrites travel-related insurance in Hawaii; and the Borgata Hotel Casino & Spa in Atlantic City, New Jersey. As of December 31, 2015, it owned and managed 1,243,007 square feet of casino space comprising 29,736 slot machines, 757 table games, and 11,391 hotel rooms. Boyd Gaming Corporation was founded in 1988 and is headquartered in Las Vegas, Nevada.

 

Stocks in the Spotlight: Teradyne, Inc. (TER), Exact Sciences Corporation (EXAS), Brocade Communications Systems, Inc. (BRCD)

Teradyne, Inc. (TER) had a active trading with around 2.69M shares changing hands compared to its three month average trading volume of 2.25M. The stock traded between $28.8 and $29.08 before closing at the price of $28.95 with 0% change on the day. The North Reading Massachusetts 01864 based company is currently trading 63.7% above its 52 week low of $18.07 and -0.28% below its 52 week high of $29.09. Both the RSI indicator and target price of 70.72 and $29.47 respectively, lead us to believe that it could drop over the coming weeks.

Teradyne, Inc. designs, develops, manufactures, and sells automatic test equipment worldwide. Its Semiconductor Test segment designs, manufactures, sells, and supports semiconductor test products and services for wafer level and device package testing in automotive, industrial, communications, consumer, computer and electronic game applications, and others. This segment offers FLEX test platform systems; Magnum platform that tests memory devices, such as flash memory and dynamic random access memory; J750 test system to address the highest volume semiconductor devices; and ETS platform for use by semiconductor manufacturers, and assembly and test subcontractors in the low pin count analog/mixed signal discrete markets. It serves integrated device manufacturers (IDMs) that integrate the fabrication of silicon wafers into their business; fabless companies, which outsource the manufacturing of silicon wafers; foundries; and outsourced semiconductor assembly and test providers. The company’s Wireless Test segment designs, develops, and supports wireless test equipment for developing and manufacturing wireless devices, including smart phones, tablets, notebooks, laptops, personal computer peripherals, and other Wi-Fi, Bluetooth, and cellular enabled devices. This segment offers IQxstream solution for testing GSM, EDGE, CDMA2000, TD-SCDMA, WCDMA, HSPA+, LTE-FDD, TD_LTE, and LTE-A technologies for calibration and verification of smartphones, tablets, small cell wireless gateways, and embedded cellular modules; test equipment for connectivity testing; IQfact chipset software; and modular wireless test instruments. The company’s System Test segment offers defense/aerospace test instrumentation and systems; storage test systems; and circuit-board test and inspection systems. Its Industrial Automation segment provides collaborative robots for manufacturing and light industrial customers. The company was founded in 1960 and is headquartered in North Reading, Massachusetts.

Exact Sciences Corporation (EXAS) continued its upward trend with the stock climbing 4.18% or $0.79 to close the day at $19.69 on active trading volume of 2.67M shares, compared to its three month average trading volume of 2.42M. The Madison Wisconsin 53719 based company has been outperforming the medical laboratories & research group over the past 52 weeks, with the stock gaining 197.88%, compared to the industry which has advanced 25.02% over the same period. With RSI of 68.61, the stock should still continue to rise and get closer to its one year target estimate of $20.88, making it a hold for now.

Exact Sciences Corporation, a molecular diagnostics company, focuses on developing products for the early detection and prevention of various cancers. The company develops the Cologuard, a non-invasive stool-based DNA screening test for the early detection of colorectal cancer and pre-cancer. Its Cologuard test includes a protein marker to detect blood in the stool, utilizing an antibody-based fecal immunochemical test. The company has a collaboration, license, and purchase agreement with Genzyme Corporation, as well as with MAYO Foundation for Medical Education and Research for developing tests to detect lung, pancreatic, and esophageal cancers. Exact Sciences Corporation was founded in 1995 and is headquartered in Madison, Wisconsin.

Brocade Communications Systems, Inc. (BRCD) shares were down in last trading by -0.08% to $12.33. It experienced lighter than average volume on day. The stock decreased in value by almost -0.56% over the past week and fell -1.12% in the past month. It is currently trading -0.88% below its 50 day moving average and 21.1% above its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -1.67% decrease in value from its one year high of $12.54. The RSI indicator value of 35.08, lead us to believe that it is a hold for now.

Brocade Communications Systems, Inc. provides storage area networking (SAN) and Internet protocol (IP) networking solutions for businesses and organizations worldwide. It operates through three segments: SAN Products, IP Networking Products, and Global Services. The SAN Products segment offers infrastructure products and solutions, such as fiber channel SAN backbones, directors, and fabric/embedded switches that assist customers in the development and deployment of storage and server consolidation, disaster recovery, and data security, as well as to meet compliance requirements regarding data management; and FC fabric extension, analytics, switching, and routing solutions. The IP Networking Products segment provides Layer 2 and Layer 3 Ethernet switches and routers to connect users over private and public networks, including local area, metro, and within and across data centers. This segment also provides converged network products; a portfolio of related software and hardware-based data networking offerings; Layer 4-7 products that are designed for application traffic management and server load balancing; and a range of wireless products for the network edge. The Global Services segment offers break/fix maintenance, installation, consulting, network management and software maintenance, and customer support services. The company serves various enterprises and service providers, such as telecommunication firms, cable operators, and mobile carriers. The company markets and sells its products and services to end-user customers directly, as well as through various distribution partners, including original equipment manufacturers, distributors, systems integrators, and value-added resellers. Brocade Communications Systems, Inc. was founded in 1995 and is headquartered in San Jose, California.

 

Stocks In Action: Ocwen Financial Corporation (OCN), WisdomTree Investments, Inc. (WETF), Tenet Healthcare Corp. (THC)

Ocwen Financial Corporation (OCN) traded within a range of $5.82 to $5.94 after opening the day at $5.87. The company has seen its stock increase in value by 8.16% so far this year. The stock was down close to -0.17% on light volume in last trading session and closed at $5.83 per share. After the recent fall, the stock is currently holding -9.05% below its 52 week high of $6.41 and 351.94% above its 12-month low of $1.29. The shares are up by over 21.46% in the last three months, and the RSI indicator value of 67.48 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Ocwen Financial Corporation, a financial services holding company, engages in servicing and origination of mortgage loans in the United States. Its Servicing segment provides residential and commercial mortgage loan servicing, special servicing, and asset management services to owners of mortgage loans and foreclosed real estate. This segment’s residential servicing portfolio includes conventional, government insured, and non-agency loans. The company’s Lending segment originates and purchases conventional and government-insured residential forward and reverse mortgage loans primarily through its correspondent lending arrangements, broker relationships, and directly with mortgage customers. Ocwen Financial Corporation was founded in 1988 and is headquartered in West Palm Beach, Florida.

WisdomTree Investments, Inc. (WETF) continued its upward trend with the stock climbing 1.83% or $0.16 to close the day at $8.92 on light trading volume of 2.01M shares, compared to its three month average trading volume of 2.61M. The New York New York 10167 based company has been underperforming the asset management group over the past 52 weeks, with the stock losing -24.85%, compared to the industry which has advanced 32.86% over the same period. With RSI of 33, the stock should still continue to rise and get closer to its one year target estimate of $9.72, making it a hold for now.

WisdomTree Investments, Inc., through its subsidiaries, operates as an exchange-traded funds (ETFs) sponsor and asset manager. It offers ETFs in equities, currency, fixed income, and alternatives asset classes. The company also licenses its indexes to third parties for proprietary products, as well as offers a platform to promote the use of WisdomTree ETFs in 401(k) plans. It develops index using its fundamentally weighted index methodology. In addition, the company provides investment advisory services. The company was founded in 1985 and is based in New York, New York.

Tenet Healthcare Corp. (THC) gained $0.62 to close the day at a new closing price of $19.86, a 3.22% increase in value from its previous closing price that moved the stock 41.25% above its 52 week low of $14.06. A total of 2.01M shares exchanged hands during the day compared with its three month average trading volume of 2.6M. The stock, which fluctuated between $19.2 and $19.88 during the day, currently situated -41.73% below its 52 week high. The stock is up by 4.58% in the past one month and up by 21.1% over the past three months. With a one year target estimate of $23.69 and RSI of 72.51, the stock still has upside potential, making it a sell for now.

Tenet Healthcare Corp., together with its subsidiaries, primarily operates acute care hospitals and related healthcare facilities. The company operates through three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology services, respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive, critical, and coronary care units; physical therapy, orthopedic, oncology, and outpatient services; tertiary care services, including open-heart surgery, neonatal intensive care, and neurosciences; quaternary care services for heart, liver, kidney, and bone marrow transplants; quaternary pediatric and burn services; gamma-knife brain surgery; and cyberknife radiation therapy for tumors and lesions in the brain, lung, neck, and spine. In addition, it offers clinical research programs related to cardiovascular and pulmonary diseases, musculoskeletal disorders, neurological disorders, genitourinary diseases, and various cancers, as well as drug and medical device studies. Further, the company operates freestanding ambulatory surgery and imaging centers, short-stay surgical facilities, and Aspen’s hospitals and clinics. Additionally, it offers operational management for patient access, accounts receivable management, health information management, revenue integrity, and patient financial services; communications and engagement solutions; and clinical integration, financial risk management, and population health management services. As of December 31, 2015, the company operated 86 hospitals, 20 short-stay surgical hospitals, and approximately 475 outpatient centers; and 9 private hospitals and clinics, as well as 249 ambulatory surgery, 20 imaging, and 35 urgent care centers in the United Kingdom. Tenet Healthcare Corp. was founded in 1967 and is headquartered in Dallas, Texas.

 

Equities Trend Analysis: HollyFrontier Corporation (HFC), Achillion Pharmaceuticals, Inc. (ACHN), Duke Realty Corporation (DRE)

HollyFrontier Corporation (HFC) grew with the stock adding 0.77% or $0.23 to close at $30.15 on light trading volume of 1.98M compared its three months average trading volume of 3.07M. The Dallas Texas 75201 based company operating under the Oil & Gas Refining & Marketing industry has been trending up for the last 52 weeks, with the shares price now 1.5% up for the period and down by -7.97% so far this year. With price target of $34.42 and a 39.86% rebound from 52-week low, HollyFrontier Corporation has plenty of upside potential, making it a hold with a view buy.

HollyFrontier Corporation operates as an independent petroleum refiner in the United States. The company operates in two segments, Refining and HEP. It primarily produces high-value refined products, such as gasoline, diesel fuel, jet fuel, specialty lubricant products, liquid petroleum gas, fuel oil, and specialty and modified asphalt. The company offers its products to other refiners, convenience store chains, independent marketers, retailers, truck stop chains, wholesalers, railroads, governmental entities, paving contractors or manufacturers, and commercial and specialty markets, as well as for commercial airline use. It owns and operates five refineries with a combined crude oil processing capacity of approximately 443,000 barrels per day in El Dorado, Kansas; Tulsa, Oklahoma; Artesia, New Mexico; Cheyenne, Wyoming; Woods Cross, Utah, as well as owns and operates asphalt terminals in Arizona, New Mexico, and Oklahoma; and vacuum distillation and other facilities in Lovington, New Mexico. HollyFrontier Corporation’s refineries serve markets in the Mid-Continent, Southwest, and Rocky Mountain regions of the United States. The company was formerly known as Holly Corporation and changed its name to HollyFrontier Corporation as a result of its merger with Frontier Oil Corporation in July 2011. HollyFrontier Corporation was founded in 1947 and is based in Dallas, Texas.

Achillion Pharmaceuticals, Inc. (ACHN) had a active trading with around 1.98M shares changing hands compared to its three month average trading volume of 1.7M. The stock traded between $4.4 and $4.72 before closing at the price of $4.71 with 5.61% change on the day. The New Haven Connecticut 06511 based company is currently trading 24.6% above its 52 week low of $3.78 and -53.18% below its 52 week high of $10.06. Both the RSI indicator and target price of  and $9.05 respectively, lead us to believe that it could rise over the coming weeks.

Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes small molecule drug therapies for infectious diseases and immune system disorders in the United States and internationally. Its drug candidates for treating chronic hepatitis C virus (HCV) infection comprise Odalasvir, a NS5A inhibitor, which has completed Phase IIa clinical trials; ACH-3422, a NS5B nucleotide polymerase inhibitor; and Sovaprevir, a NS3 protease inhibitor, which has completed Phase II clinical trial. The company is also developing ACH-4471, a complement factor D inhibitor that is in Phase I clinical trial to treat patients with paroxysmal nocturnal hemoglobinuria and one additional systemic ultra-rare disease; and other factor D inhibitors. It has a license and development agreement with Ora, Inc. for the development and commercialization of ACH-702, an antibacterial drug candidate that is delivered topically or locally; and license and collaboration arrangement with Janssen Pharmaceuticals Inc. to develop and commercialize antiviral drug candidates for treating HCV infection. The company was founded in 1998 and is headquartered in New Haven, Connecticut.

Duke Realty Corporation (DRE) saw its value decrease by -0.56% as the stock dropped $-0.14 to finish the day at a closing price of $24.97. The stock was lighter in trading and has fluctuated between $19.87-$28.99 per share for the past year. The shares, which traded within a range of $24.73 to $25.11 during the day, are up by 6.38% in the past three months and down by -9.6% over the past six months. It is currently trading -0.72% below its 20 day moving average and -3.04% below its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $27.87 a share over the next twelve months. The current relative strength index (RSI) reading is 45.81.The technical indicator lead us to believe there will be no major movement any time soon, hold.

Duke Realty Corporation is an equity real estate investment trust. The firm invests in the real estate markets of the United States. It offers a single point of responsibility for all aspects of a project, including leasing, asset management, construction and development. The firm primarily invests in commercial real estate sector. It was founded in 1972 and is headquartered in Indianapolis, Indiana with additional offices in Atlanta, Georgia; Baltimore, Maryland; Central Florida; Chicago, Illinois; Cincinnati, Ohio; Columbus, Ohio; Dallas, Texas; Houston, Texas; Minneapolis, Minnesota; Nashville, Tennessee; New Jersey; Northern and Southern California; Pennsylvania; Phoenix, Arizona; Raleigh, North Carolina; St. Louis, Missouri; Savannah, Georgia; Seattle, Washington; Washington D.C.; and South Florida.

 

Stocks Buzz: TEGNA Inc. (TGNA), American Outdoor Brands Corporation (AOBC), Antares Pharma, Inc. (ATRS)

TEGNA Inc. (TGNA) continued its upward trend with the stock climbing 0.75% or $0.18 to close the day at $24.33 on active trading volume of 1.8M shares, compared to its three month average trading volume of 1.78M. The McLean Virginia 22107 based company has been outperforming the broadcasting – tv group over the past 52 weeks, with the stock gaining 2.9%, compared to the industry which has advanced 25.4% over the same period. With RSI of 79.03, the stock should still continue to rise and get closer to its one year target estimate of $24.57, making it a hold for now.

TEGNA Inc. engages in media and digital businesses in the United States. The company operates in two segments, Media and Digital. It operates 46 television stations that produce local programming, such as news, sports, and entertainment. The company also operates Cars.com, an online destination for automotive consumers that offers information about car shopping, selling, and servicing; CareerBuilder, which provides human capital solutions, such as employment data and labor market analysis software, talent management software, and other advertising and recruitment solutions; G/O Digital that provides digital marketing services for local businesses; and Cofactor, a digital marketing company that enable brands to deliver content. In addition, it offers advertising and marketing solutions. The company serves approximately 90 million customers through its broadcast and digital media platforms. The company was formerly known as Gannett Co., Inc. and changed its name to TEGNA Inc. in June 2015. TEGNA Inc. was founded in 1906 and is headquartered in McLean, Virginia.

American Outdoor Brands Corporation (AOBC) retreated with the stock falling -1.98% or $-0.38 to close at $18.84 on light trading volume of 1.8M compared its three months average trading volume of 1.9M. The Springfield Massachusetts 01104 based company has been trending down for the last 52 weeks, with the shares price now -18.76% down for the period and down by -10.63% so far this year. With price target of $25.75 and a 0.16% rebound from 52-week low, American Outdoor Brands Corporation has plenty of upside potential, making it a hold with a view buy.

American Outdoor Brands Corporation manufactures and sells firearm products and accessories. The company operates in two segments, Firearms and Accessories. It offers handguns, long guns, hunting rifles, black powder firearms, handcuffs and restraints, and firearm-related products. The company also provides accessories, such as reloading, gunsmithing tools, gun cleaning supplies, tree saws, shooting and field rests, gun vises, hearing protection, ammo tumblers, and vault accessories. It sells its products under the Smith & Wesson, M&P, Thompson/Center Arms, Caldwell Shooting Supplies, Wheeler Engineering, Tipton Gun Cleaning Supplies, Frankford Arsenal Reloading Tools, Lockdown Vault Accessories, Hooyman Premium Tree Saws, BOG-POD, and Golden Rod Moisture Control brands. In addition, the company sells parts of other brands; operates a private law enforcement training facility; provides metal processing and finishing services comprising tooling, forging, heat treating, finishing, plating, and plastic injection molding, as well as engineering support services to third-party customers; and licenses trademarks to third parties. It serves gun enthusiasts; collectors; hunters; sportsmen; competitive shooters; individuals desiring home and personal protection; law enforcement and security agencies and officers; and military agencies. The company markets products through dealers, retailers, in-store retail channels, and range operations utilizing consumer-focused product marketing and promotional campaigns; social and electronic media; and in-store retail merchandising systems and strategies. It also operates Websites; and online retail stores that sells hunting and shooting accessories, branded products, apparel, and related shooting supplies. The company was formerly known as Smith & Wesson Holding Corporation and changed its name to American Outdoor Brands Corporation in January 2017. The company was founded in 1852 and is based in Springfield, Massachusetts.

Antares Pharma, Inc. (ATRS) continued its upward trend with the stock climbing 5.81% or $0.14 to close the day at $2.55 on lower than average trading volume of 1.8M shares, compared to its three month average trading volume of 903.48K. The Ewing New Jersey 08628 based company has been outperforming the medical instruments & supplies companies by 32.6965% for last three months and its recent gains have pushed the stock slightly up 9.44% YTD, versus the medical instruments & supplies industry which is up 8.7% for the same period. The RSI of 72.42 indicates the stock is overbought at the current levels, sell for now.

Antares Pharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies worldwide. The company’s injection products include OTREXUP that comprises of pre-filled methotrexate syringe and VIBEX self-injection system to enable rheumatoid arthritis (RA) and psoriasis patients to self-inject methotrexate at home; ZOMA-Jet and Twin-Jector, a needle-free auto injector to deliver human growth hormone treatment to children without the use of a needle; and VIBEX disposable pressure-assisted auto injectors. It also offers Elestrin gel for the treatment of moderate-to-severe vasomotor symptoms associated with menopause; and Gelnique, an oxybutynin gel product for the treatment of overactive bladder. In addition, the company is developing VIBEX auto injectors for treating anaphylaxis; disposable pen injectors for diabetes; VIBEX QuickShot (QS) auto injectors for reducing risk of preterm birth; VIBEX QS Testosterone for testosterone replacement therapy for men who have testosterone deficiency; and Vibex QS M for the treatment of CNS indication. Antares Pharma, Inc. has collaborative and license agreements with Ferring Pharmaceuticals Inc. and Ferring B.V.; JCR Pharmaceuticals Co., Ltd.; Teva Pharmaceutical Industries, Ltd.; Actavis plc; Meda Pharmaceuticals, Inc.; and AMAG Pharmaceuticals, Inc. The company was founded in 1979 and is headquartered in Ewing, New Jersey.

 

Three Movers to Watch for: Murphy Oil Corporation (MUR), Cloud Peak Energy Inc. (CLD), FelCor Lodging Trust Incorporated (FCH)

Murphy Oil Corporation (MUR) retreated with the stock falling -0.88% or $-0.25 to close at $28.19 on light trading volume of 1.67M compared its three months average trading volume of 2.87M. The El Dorado Arkansas 71730 based company operating under the Independent Oil & Gas industry has been trending up for the last 52 weeks, with the shares price now 63% up for the period and down by -8.64% so far this year. With price target of $32.56 and a 91.55% rebound from 52-week low, Murphy Oil Corporation has plenty of upside potential, making it a hold with a view buy.

Murphy Oil Corporation operates as an oil and gas exploration and production company worldwide. It explores for and produces crude oil, natural gas, and natural gas liquids. The company was formerly known as Murphy Corporation and changed its name to Murphy Oil Corporation in 1964. Murphy Oil Corporation was founded in 1950 and is headquartered in El Dorado, Arkansas.

Cloud Peak Energy Inc. (CLD) dropped $-0.24 to close the day at a new closing price of $5.66, a -4.07% decrease in value from its previous closing price that moved the stock 307.19% above its 52 week low of $1.39. A total of 1.67M shares exchanged hands during the day compared with its three month average trading volume of 1.76M. The stock, which fluctuated between $5.65 and $5.91 during the day, currently situated -29.6% below its 52 week high. The stock is up by 8.22% in the past one month and down by -23.2% over the past three months. With a one year target estimate of $6.56 and RSI of 50.98, the stock still has upside potential, making it a hold for now.

Cloud Peak Energy Inc. produces coal in the Powder River Basin in the United States. The company operates through Owned and Operated Mines, and Logistics and Related Activities. It owns and operates three surface coal mines comprising the Antelope Mine and the Cordero Rojo Mine located in Wyoming; and the Spring Creek Mine located in Montana. These mines produce subbituminous thermal coal with low sulfur content. The company sells its coal primarily to domestic and foreign electric utilities. As of December 31, 2015, it controlled approximately 1.1 billion tons of proven and probable reserves. The company also has two development projects comprising the Youngs Creek project, an undeveloped surface mine project located in Wyoming and the Big Metal project located in southeast Montana. In addition, it offers logistics and related services, including the purchase of coal from third parties, as well as the contracting and coordination of the transportation and other handling services from third-party operators. Cloud Peak Energy Inc. was founded in 1993 and is headquartered in Gillette, Wyoming.

FelCor Lodging Trust Incorporated (FCH) shares were down in last trading by -0.13% to $7.54. It experienced higher than average volume on day. The stock decreased in value by almost -1.18% over the past week and fell -2.58% in the past month. It is currently trading -3.91% below its 50 day moving average and 10.52% above its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -17.42% decrease in value from its one year high of $9.13. The RSI indicator value of 41.99, lead us to believe that it is a hold for now.

FelCor Lodging Trust Incorporated is a publicly owned real estate investment trust. The firm engages in investment and management of properties in the hospitality industry. It invests in the real estate markets of the United States. The firm primarily invests in hotels with a focus on the ownership of upper-upscale, full-service hotels and resorts. It was formerly known as FelCor Suite Hotels, Inc. FelCor Lodging Trust was founded in 1994 and is based in Irving, Texas.

 

Stocks To Track: Caesars Entertainment Corporation (CZR), LKQ Corporation (LKQ), Scripps Networks Interactive, Inc. (SNI)

Caesars Entertainment Corporation (CZR) climbed 4.55% during last trading as the stock added $0.4 to finish the day at $9.2 with about 1.63M shares changing hands, compared to its three month average trading volume of 891.28K. The $1.38B market cap company, which fluctuated between $8.5 and $9.4 during the day, currently situated 70.69% above its 52 week low of $5.39 and -15.13% away from its one year high of $10.84. The RSI of 61.05 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Caesars Entertainment Corporation, through its subsidiaries, provides casino-entertainment and hospitality services in the United States and internationally. It operates in three segments: Caesars Entertainment Resort Properties, Caesars Growth Partners Casino Properties and Developments, and Caesars Interactive Entertainment. The company owns, operates, or manages casinos; and operates Harrah’s Atlantic City Waterfront Conference Center and The LINQ Hotel & Casino for casino guests visiting for gaming and other casino entertainment options, and non-casino guests visiting for other purposes. It operates 14,000 slot machines and 1,200 table games, as well as other games comprising keno, poker, and race and sports books; and buffets, restaurants, bars, nightclubs, and lounges located throughout the company’s casinos, as well as banquets and room service. As of December 31, 2015, the company owned and operated 12 casinos. It also manages 28 casino properties owned by Caesars Entertainment Operating Company, Inc.; and 10 casinos owned by unrelated third parties. In addition, the company operates online gaming business that provides social games on Facebook and other social media Websites, and mobile application platforms, as well as various real money games in Nevada and New Jersey. Further, it owns the World Series of Poker tournaments and brand, and licenses trademarks for various products and businesses related to this brand. Additionally, the company engages in the third-party leasing of arrangements at its casino properties; provides various retail and entertainment offerings in its casinos, as well as The LINQ promenade, an open-air dining, entertainment, and retail development; and operates The High Roller, a 550-foot observation wheel. The company was formerly known as Harrah’s Entertainment Inc. and changed its name to Caesars Entertainment Corporation in November 2010. Caesars Entertainment Corporation was founded in 1937 and is based in Las Vegas, Nevada.

LKQ Corporation (LKQ) gained $0.26 to close the day at a new closing price of $31.92, a 0.82% increase in value from its previous closing price that moved the stock 28.55% above its 52 week low of $24.43. A total of 1.63M shares exchanged hands during the day compared with its three month average trading volume of 1.89M. The stock, which fluctuated between $31.37 and $32.06 during the day, currently situated -12.19% below its 52 week high. The stock is up by 1.01% in the past one month and down by -1.85% over the past three months. With a one year target estimate of $38.91 and RSI of 54.23, the stock still has upside potential, making it a hold for now.

LKQ Corporation, together with its subsidiaries, distributes replacement parts, components, and systems used in the repair and maintenance of vehicles in the United States, the United Kingdom, and internationally. It operates in five segments: Wholesale – North America; Europe; Specialty; Glass; and Self Service. The company distributes various products, including aftermarket collision and mechanical products; recycled collision and mechanical products; and refurbished collision products, including wheels, bumper covers and lights, and remanufactured engines. It also offers recycled products, such as engines, transmissions, and door assemblies; sheet metal products comprising trunk lids, fenders and hoods, lights, and bumper assemblies; and refurbish products consisting of wheels, lights, plastic bumpers, and chrome bumpers, as well as heavy-duty truck products. In addition, the company sells scrap metal and other materials to recyclers; and extracts and sells the precious metals contained in various of recycled parts, such as catalytic converters. Further, it sells parts from older cars and light-duty trucks directly to consumers; and operates self service retail facilities that sell recycled automotive products from end-of-life-vehicles under the LKQ Pick Your Part name. Additionally, the company distributes and markets trucks and off-roads; speed and performance, and towing equipment and accessories; recreational vehicles; wheels, tires, and performance handling products; and miscellaneous accessories. It also manufactures and distributes automotive glass products; and distributes specialty vehicle aftermarket products and accessories. It primarily serves collision and mechanical repair shops, new and used car dealerships, metal recyclers, and specialty vehicle retailers and equipment installers, as well as retail customers. The company was founded in 1998 and is headquartered in Chicago, Illinois.

Scripps Networks Interactive, Inc. (SNI) had a light trading with around 1.62M shares changing hands compared to its three month average trading volume of 970.64K. The stock traded between $76.92 and $77.86 before closing at the price of $77.18 with 0.36% change on the day. The Knoxville Tennessee 37932 based company is currently trading 47.31% above its 52 week low of $54.1 and -1.71% below its 52 week high of $78.52. Both the RSI indicator and target price of 62.87 and $71.94 respectively, lead us to believe that it should be put on hold over the coming weeks.

Scripps Networks Interactive, Inc. develops lifestyle-oriented content for linear and interactive video platforms in the United States, the United Kingdom and other European markets, the Middle East and Africa, the Asia-Pacific, and Latin America. The company delivers content that focuses on specifically defined topics of interest for audiences and advertisers. It operates national television networks, including Home and Garden Television (HGTV), Food Network, Travel Channel, DIY Network, Cooking Channel, and Great American Country; and Websites comprising HGTV.com, FoodNetwork.com, TravelChannel.com, DIYNetwork.com, CookingChanneltv.com, and GACTV.com that are associated with the aforementioned television brands and other Internet-based businesses serving home, food, and travel related categories. The company also operates a portfolio of free-to-air and pay-TV lifestyle, and entertainment networks internationally, including TVN, TVN24, TVN Style, TTV, TVN Turbo, TVN24 Biznes i Swiat, and TVN Media. In addition, it licenses its content to third parties; and brands for consumer products, such as videos, books, kitchenware, and tools. Scripps Networks Interactive, Inc. is headquartered in Knoxville, Tennessee.

 

Stocks on the Move: Universal Display Corporation (OLED), COPsync, Inc. (COYN), VCA Inc. (WOOF)

Universal Display Corporation (OLED) continued its upward trend with the stock climbing 4.77% or $3.2 to close the day at $70.35 on light trading volume of 1.49M shares, compared to its three month average trading volume of 473.15K. The Ewing New Jersey 08618 based company has been outperforming the semiconductor equipment & materials group over the past 52 weeks, with the stock gaining 52.87%, compared to the industry which has advanced 51.71% over the same period. With RSI of 71.09, the stock should still continue to rise and get closer to its one year target estimate of $69, making it a hold for now.

Universal Display Corporation engages in the research, development, and commercialization of organic light emitting diode (OLED) technologies and materials for use in flat panel displays and solid-state lighting applications. It owns, exclusively licenses, or has the sole right to sublicense approximately 3,600 patents issued and pending worldwide. The company licenses and supplies its proprietary UniversalPHOLED phosphorescent OLED technologies and materials to display manufacturers and others. It is also involved in the research, development, and commercialization of other OLED device and manufacturing technologies, including FOLED that are flexible OLEDs for the fabrication of OLEDs on flexible substrates; encapsulation technology for the packaging of flexible OLEDs and other thin-film devices, as well as for use as a barrier film for plastic substrates; UniversalP2OLED, which are printable phosphorescent OLEDs; OVJP, an organic vapor jet printing technology; OVPD, an organic vapor phase deposition for manufacturing a small molecule OLED; and TOLED, which are transparent OLEDs for the fabrication of OLEDs that have transparent cathodes. In addition, the company provides technology development and support services, including government contract work and support provided to third parties for the commercialization of their OLED products. It has strategic relationships with Samsung Display Co., Ltd.; LG Display Co., Ltd.; Tohoku Pioneer Corporation; Konica Minolta Holdings Inc.; AU Optronics Corporation; Innolux Corporation; Kaneka Corporation; Philips Technologic GmbH; Sumitomo Chemical Co., Ltd.; Sony Corporation; Lumiotec, Inc.; LG Chem, Ltd.; NEC Lighting, Ltd.; BOE Technology Group Co., Ltd.; and OLEDWorks L.L.C. The company was founded in 1985 and is headquartered in Ewing, New Jersey.

COPsync, Inc. (COYN) fell -33.32% during last trading as the stock lost $-0.22 to finish the day at $0.44 with about 1.49M shares changing hands, compared to its three month average trading volume of 185.48K. The $4.78M market cap company, which fluctuated between $0.4257 and $0.54 during the day, currently situated 4.61% above its 52 week low of $0.4207 and -83.45% away from its one year high of $2.66. The RSI of 41.58 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

COPsync, Inc. operates a real-time law enforcement mobile data information system in the United States. It provides COPsync Network, a software as a service, which enables patrol officers to collect, report, and share critical data in real-time at the point of incident and obtain instant access to various local, state, and federal law enforcement databases. The company’s COPsync Network service also enables officers to electronically write tickets; process DUI and other arrests; and document accidents and other incidents, as well as allows dispatchers and officers to send be on the lookout and other alerts of child kidnappings, robberies, car thefts, police pursuits, and other crimes in progress to officers on the COPsync Network. In addition, it offers COPsync911, an emergency threat notification service; VidTac, an in-vehicle software-driven video camera system for law enforcement and fire departments; WARRANTsync, a statewide misdemeanor warrant clearing database; and COURTsync, a court security and efficiency application. The company sells its products and services through direct sales channels, and distributors and resellers. COPsync, Inc. was founded in 2005 and is based in Addison, Texas.

VCA Inc. (WOOF) saw its value increase by 0.18% as the stock gained $0.16 to finish the day at a closing price of $90.93. The stock was lighter in trading and has fluctuated between $49.9-$91.58 per share for the past year. The shares, which traded within a range of $90.77 to $90.99 during the day, are up by 42.41% in the past three months and up by 25.56% over the past six months. It is currently trading 0.21% above its 20 day moving average and 14.86% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $76.01 a share over the next twelve months. The current relative strength index (RSI) reading is 91.92. The technical indicator do not lead us to believe the stock will see more gains any time soon.

VCA Inc. operates as an animal healthcare company in the United States and Canada. It operates in two segments, Animal Hospital and Laboratory. The Animal Hospital segment offers general medical and surgical services for companion animals, as well as specialized treatments comprising diagnostic, internal medicine, oncology, neurology, endocrinology, ophthalmology, dermatology, and cardiology services; and sells related retail and pharmaceutical products. It also provides specialty pet products, including pet food, vitamins, therapeutic shampoos and conditioners, flea collars and sprays, and other accessory products; and additional services, such as grooming, bathing, and boarding services. In addition, this segment performs various pet wellness programs, such as health examinations, diagnostic testing, routine vaccinations, spaying, neutering, and dental care. As of December 31, 2015, it operated or managed 682 animal hospitals. The Laboratory segment offers testing and consulting services used by veterinarians in the detection, diagnosis, evaluation, monitoring, treatment, and prevention of diseases and other conditions affecting animals. This segment serves animal hospitals, animal practices, universities, and other government organizations. It operated a network of 60 laboratories. VCA Inc. also sells digital radiography and ultrasound imaging equipment, related computer hardware, software, and ancillary services to the veterinary market, as well as provides education and training, consulting, and mobile imaging services; and franchises pet services, including dog day care, overnight boarding, grooming, and other ancillary services at pet care facilities. The company was formerly known as VCA Antech, Inc. and changed its name to VCA Inc. in June 2014. VCA Inc. was founded in 1986 and is headquartered in Los Angeles, California.

 

Stocks Trending Alert: Amgen Inc. (AMGN), State Street Corporation (STT), Ameriprise Financial, Inc. (AMP)

Amgen Inc. (AMGN) saw its value increase by 0.23% as the stock gained $0.39 to finish the day at a closing price of $168.05. The stock was lighter in trading and has fluctuated between $133.64-$176.85 per share for the past year. The shares, which traded within a range of $165.57 to $168.07 during the day, are up by 14.3% in the past three months and down by -2.42% over the past six months. It is currently trading 6.04% above its 20 day moving average and 10.45% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $182.88 a share over the next twelve months. The current relative strength index (RSI) reading is 72.06.The technical indicator do not lead us to believe the stock will see more gains any time soon.

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It offers products for the treatment of illness in the areas of oncology/hematology, cardiovascular, inflammation, bone health, nephrology, and neuroscience. The company’s products include Neulasta, a pegylated protein for the treatment of cancer patients; NEUPOGEN, a recombinant-methionyl human granulocyte colony-stimulating factor for reducing the incidence of infection for patients with non-myeloid malignancies; and Enbrel to treat rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis. Its products also comprise EPOGEN to treat a lower-than-normal number of red blood cells caused by chronic kidney disease (CKD) in patients on dialysis; Aranesp for treating anemia; XGEVA for the prevention of skeletal-related events; Prolia to treat postmenopausal women with osteoporosis; Repatha for the treatment of cholesterol; and Sensipar/Mimpara products for use in the treatment of secondary hyperparathyroidism in CKD patients on dialysis. The company’s other marketed products include Kyprolis, a proteasome inhibitor to treat patients with multiple myeloma and small-cell lung cancer; Nplate, a thrombopoietic compound; Vectibix, a human monoclonal antibody; and BLINCYTO for the treatment of patients with Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia. It also develops various products that are in various clinical trials. The company serves pharmaceutical wholesale distributors; and physicians or their clinics, dialysis centers, hospitals, and pharmacies, as well as consumers. It has collaborative agreements with Xencor, Inc; UCB; Novartis AG; Bayer HealthCare Pharmaceuticals Inc; Advaxis, Inc.; Dr. Reddy’s Laboratories Ltd.; Biocartis Group NV; and Nuevolution AB. The company also has a strategic collaboration with Immatics Biotechnologies GmbH. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.

State Street Corporation (STT) shares were up in last trading by 2.72% to $81.45. It experienced higher than average volume on day. The stock increased in value by almost 5.1% over the past week and fell -1.78% in the past month. It is currently trading 3.08% above its 50 day moving average and 18.57% above its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -2.44% decrease in value from its one year high of $83.49. The RSI indicator value of 63.88, lead us to believe that it is a hold for now.

State Street Corporation, through its subsidiaries, provides a range of financial products and services to institutional investors worldwide. The company offers investment servicing products and services, including custody; product- and participant-level accounting; daily pricing and administration; master trust and master custody; record-keeping; cash management; foreign exchange, brokerage, and other trading services; securities finance; deposit and short-term investment facilities; loans and lease financing; investment manager and alternative investment manager operations outsourcing; and performance, risk, and compliance analytics. It also provides investment management services, such as investment management, investment research, and investment advisory services to corporations, public funds, and other sophisticated investors, as well as offers active and passive asset management strategies across equity, fixed-income, and cash asset classes. The company offers its products and services to mutual funds, collective investment funds and other investment pools, corporate and public retirement plans, insurance companies, foundations, endowments, and investment managers. State Street Corporation was founded in 1792 and is headquartered in Boston, Massachusetts.

Ameriprise Financial, Inc. (AMP) traded within a range of $125.57 to $128.38 after opening the day at $125.58. The company has seen its stock increase in value by 15.92% so far this year. The stock was up close to 1.32% on active volume in last trading session and closed at $127.81 per share. After the recent gain, the stock is currently holding 0.73% above its 52 week high of $128.38 and 63.95% above its 12-month low of $80.39. The shares are up by over 16.02% in the last three months, and the RSI indicator value of 74.4 is bearish. The technical indicator is offering a warning sign that the stock can’t keep current pace going.

Ameriprise Financial, Inc., through its subsidiaries, provides various financial products and services to individual and institutional clients in the United States and internationally. The company’s Advice & Wealth Management segment provides financial planning and advice, as well as full-service brokerage services primarily to retail clients through its advisors. Its Asset Management segment offers investment management and advice, and investment products to retail, high net worth, and institutional clients through unaffiliated third party financial institutions and institutional sales force. This segment’s products include U.S. mutual funds and their non-U.S. equivalents, exchange-traded funds, variable product funds underlying insurance, and annuity separate accounts; and institutional asset management products, such as traditional asset classes, separately managed accounts, individually managed accounts, collateralized loan obligations, hedge funds, collective funds, and property funds. The company’s Annuities segment provides variable and fixed annuity products to individual clients through affiliated and unaffiliated advisors, and financial institutions. Its Protection segment offers various products to address the protection and risk management needs of retail clients, including life, disability income, and property casualty insurance through advisors and affinity relationships. The company was formerly known as American Express Financial Corporation and changed its name to Ameriprise Financial, Inc. in September 2005. Ameriprise Financial, Inc. was founded in 1894 and is headquartered in Minneapolis, Minnesota.